gip vs glp-1 Science Behind GLP 1 and Glucagon Receptor Agonists for Obesity Research | News & Announcements Gut inflammation in mice is
Description
Both are subject to how others perceive them
Key players such as Novo Nordisk (DK), Eli Lilly (US), and Sanofi (FR) are at the forefront, each employing distinct strategies to enhance their market positions
Nevertheless, GLP-1 RAs have gastrointestinal adverse effects such as abdominal pain, constipation, diarrhea, nausea, and vomiting [7]
Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1
doi: 10.1158/1078-0432.CCR-06-2965
